AF
AVBP icon

Allworth Financial’s ArriVent BioPharma AVBP Stock Holding History

Allworth Financial’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04K Buy
45
+27
+150% +$610 ﹤0.01% 4561
2025
Q4 		$363 Sell
18
-6
-25% -$125 ﹤0.01% 4605
2025
Q3 		$443 Sell
24
-99
-80% -$1.95K ﹤0.01% 4466
2025
Q2 		$2.68K Buy
123
+94
+324% +$1.95K ﹤0.01% 3579
2025
Q1 		$614 Buy
+29
New +$710 ﹤0.01% 3627

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Allworth Financial's AVBP Position: Q1 2026 in Review

Allworth Financial increased its ArriVent BioPharma (AVBP) stake by 150% in Q1 2026, buying an estimated $610 and bringing the position to 45 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #4561.

Allworth Financial first reported a position in AVBP in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.68K in Q2 2025. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Allworth Financial held 45 shares of ArriVent BioPharma worth $1.04K as of Q1 2026.
  • Allworth Financial bought 27 ArriVent BioPharma shares in Q1 2026, an estimated $610.
  • ArriVent BioPharma made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4561 holding.
  • Allworth Financial first reported a position in ArriVent BioPharma in Q1 2025 and has held it in 5 quarters since.
  • Allworth Financial's ArriVent BioPharma position peaked at $2.68K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.